At a glance
ClinicalIndex Comparison RecordN/ACompleted· 742 enrolled
Drug / intervention
Voglibosedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Voglibose Tablets 0.2 / Voglibose Oral Disintegrant (OD) Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"
In Brief
An observational study evaluating Voglibose for Impaired Glucose Tolerance. Completed, enrolled 742 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the safety and efficacy of long-term use of Voglibose (Basen) to prevent progression to type 2 diabetes mellitus in participants with impaired glucose tolerance in the routine clinical setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsImpaired Glucose Tolerance
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
Primary CompletionAug 2013
First PostedNov 2013
TodayJul 2026
First PostedNov 25, 2013
Enrollment StartNov 18, 2009
Primary CompletionAug 31, 2013
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 12.6 years ago
Interventions
Voglibosedrug
Voglibose Tablets / Voglibose OD Tablets